Leukemia

Olutasidenib Capsules

olutasidenib capsules is a prescription medicine used to treat relapsed or refractory acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation

read more

EnasidenibTablets

enasidenib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.

read more

idelalisib Tablets

Idelalisib is a prescription medicine used to treat adults with: Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia (CLL) in combination with rituximab when CLL comes back after prior cancer treatment and when Rituxan treatment alone may be used due to other health problems.

read more

omacetaxine mepesuccinate Injection

omacetaxine mepesuccinate for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with omacetaxine mepesuccinate.

read more

ivosidenib tablets

Ivosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with a susceptible IDH1 mutation as detected by FDA-approved test with Acute Myeloid Leukemia & Locally Advanced or Metastatic Cholangiocarcinoma.

read more

Methylprednisolone Injection

Facilitating Access to Approved MedicationMethylprednisolone Injection Active Ingredient(s): MethylprednisoloneTrade Name: On RequestPackaging: TabletsStrength: Tablets may vary from 4 mg to 48 mg of methylprednisoloneIndications:...

read more

Glasdegib Tablets

Facilitating Access to Approved MedicationGlasdegib Tablets Active Ingredient(s): Glasdegib TabletsTrade Name: On RequestPackaging: TabletsStrength: Tablets: 100 mg, 25 mg.Indications: Glasdegib is indicated, in combination with low-dose...

read more

Inotuzumab Ozogamicin For Injection

Facilitating Access to Approved MedicationInotuzumab Ozogamicin For Injection Active Ingredient(s): Inotuzumab Ozogamicin For InjectionTrade Name: On RequestPackaging: InjectionStrength: For injection: 0.9 mg lyophilized powder in a single-dose...

read more

Nilotinib Capsules

Facilitating Access to Approved MedicationNilotinib Capsules Active Ingredient(s): Nilotinib CapsulesTrade Name: On RequestPackaging: CapsulesStrength: 2.5 milligram tabletsIndications: Nilotinib is used to treat Philadelphia chromosome...

read more

Midostaurin Capsules

Midostaurin was approved by the FDA On April 28, 2017 for the treatment of adult patients with newly diagnosed AML who are positive for oncogenic FLT3, in combination with chemotherapy The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML.

read more

Leukemia

4 + 11 =

Head Office

SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

Mobile / WhatsApp Number:

Mobile: +91 99292 77766
WhatsApp: +91 99292 77766

E Mail:

info@tretmentoptions4u.com 

Note:-
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer
Privacy Policy
Health Information

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Social Media